As a new radioactive tracer of PET/CT, 68GA-labeled PSMA ligand had good sensitivity and specificity in detecting primary prostate cancer, and showed superior diagnostic performance in both pooled as well as subgroup analysis estimates. This evidence concerns the gene FOLH1 and Familial prostate cancer.